Skip to main content
. Author manuscript; available in PMC: 2020 Jun 8.
Published in final edited form as: Basic Res Cardiol. 2019 May 31;114(4):28. doi: 10.1007/s00395-019-0737-y

Fig. 4.

Fig. 4

Loss of E2F1 reduces cardiac size without affecting cardiomyocyte hypertrophy after infarction. mRNA expression of markers of cardiac hypertrophy (a). Representative images of WGA-stained E2f1+/+ and E2f1−/− heart sections (b). Gravimetric analysis of heart size revealed reduced heart weight to tibia length (c) in E2f1−/− mice. Cardiomyocyte cross-sectional area was measured in the border zone of the infarct (“BZ”; panel d), in the infarct zone (“IZ”; panel e), and remote zone (“RZ”; panel f). An unpaired Student’s t test was used to determine significance between E2f1+/+ and E2f1−/− groups